Peter Chowka's story on NCI Undertaking a Review

Cancer patients highlight new 714X controversy and the NCI agrees to review the treatment

By Peter Chowka

(June 1, 2001) A small but dedicated group of cancer patient activists in Eastern Massachusetts has helped to bring to light what they describe as a possible cover-up of promising, preliminary test results of 714X, a controversial unconventional cancer treatment from Canada, at the prestigious Dana-Farber Cancer Institute in Boston.

A subsequent avalanche of media reporting about the story in the Boston area has resulted in Dana-Farber on May 21 calling on the National Cancer Institute (NCI) to undertake a formal review of 714X, which the NCI's Office of Cancer Complementary and Alternative Medicine (OCCAM) has agreed to do.

More at

Drug Development Group (NCI) Reviews 714X

July 21, 2003 Story from

Remember we are NOT Doctors and have NO medical training.

This site is like an Encyclopedia - there are many pages, many links on many topics.

Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.